Merging structural biology with chemical biology: Structural Chemistry at Eskitis

Structural Chemistry

Volumn 21, Issue 5, 2010, Pages 1117-1129

  Hofmann, Andreas ^a   Wang, Conan K ^a   Osman, Asiah ^a   Camp, David ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Molecular mechanisms; Protein crystallography; Protein structure function; Rational drug design

Indexed keywords

EID: 77956872162     PISSN: 10400400     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11224-010-9654-2     Document Type: Review

References (96)

1. Hofmann A, Wlodawer A (2002) PCSB-a program collection for structural biology and biophysical chemistry. Bioinformatics 18: 209-210.
2. Hofmann A (2008) ACDP-a Java application for data processing and analysis of protein circular dichroism spectra. J Appl Crystallogr 42: 137-139.
3. Dobson CM (2004) Chemical space and biology. Nature 432: 824-828.
4. Buskirk AR, Liu DR (2005) Creating small-molecule-dependent switches to modulate biological functions. Chem Biol 12: 151-161.
5. Stockwell BR (2004) Exploring biology with small organic molecules. Nature 432: 846-854.
6. Bohacek RS, McMartin C, Guida WC (1996) The art and practice of structure-based drug design: a molecular modeling perspective. Med Res Rev 16: 3-50.
7. Spring DR (2003) Diversity-oriented synthesis; a challenge for synthetic chemists. Org Biomol Chem 1: 3867-3870.
8. Newman DJ, Cragg GM (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70: 461-477.
9. Lipinski C, Lombardo F, Dominy B, Feeney P (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23: 3-25.
10. Leeson P, Davis A, Steele J (2004) Drug-like properties: guiding principles for design-or chemical prejudice? Drug Discov Today Technol 1: 189-195.
11. Teague SJ, Davis AM, Leeson PD, Oprea T (1999) The design of leadlike combinatorial libraries. Angew Chem Int Ed Engl 38: 3743-3747.
12. Hann MM, Oprea TI (2004) Pursuing the leadlikeness concept in pharmaceutical research. Curr Opin Chem Biol 8: 255-263.
13. Leeson PD, Davis AM (2004) Time-related differences in the physical property profiles of oral drugs. J Med Chem 47: 6338-6348.
14. Ganesan A (2008) The impact of natural products upon modern drug discovery. Curr Opin Chem Biol 12: 306-317.
15. Lipinski CA, Hopkins A (2004) Navigating chemical space for biology and medicine. Nature 432: 855-861.
16. Bredel M, Jacoby E (2004) Chemogenomics: an emerging strategy for rapid target and drug discovery. Nat Rev Genet 5: 262-275.
17. Golebiowski A, Klopfenstein SR, Portlock DE (2001) Lead compounds discovered from libraries. Curr Opin Chem Biol 5: 273-284.
18. Prien O (2005) Target-family-oriented focused libraries for kinases-conceptual design aspects and commercial availability. ChemBioChem 6: 500-505.
19. Player MR (2004) Target-based compound library design and synthesis. Drug Discov Today Targets 3: 48-50.
20. De Simone RW, Currie KS, Mitchell SA, Darrow JW, Pippin DA (2004) Privileged structures: applications in drug discovery. Comb Chem High Throughput Screen 7: 473-493.
21. Burke MD, Berger EM, Schreiber SL (2003) Generating diverse skeletons of small molecules combinatorially. Science 302: 613-618.
22. Fergus S, Bender A, Spring DR (2005) Assessment of structural diversity in combinatorial synthesis. Curr Opin Chem Biol 9: 304-309.
23. Camp D (2007) Establishment of an open access compound management facility in Australia to stimulate applied, basic and translational biomedical research. Drug Discov World 8: 61-66.
24. Camp D, Avery VM, Street I, Quinn RJ (2007) Progress towards establishing an open access molecular screening capability in the Australasian region. ACS Chem Biol 2: 764-767.
25. Mueller D, Davis RA, Duffy S, Avery VM, Camp D, Quinn RJ (2009) Antimalarial activity of azafluorenone alkaloids from the Australian tree Mitrephora diversifolia. J Nat Prod 72: 1538-1540.
26. Davis RA, Duffy S, Avery VM, Camp D, Hooper JNA, Quinn RJ (2010) (+)-7-Bromotrypargine, an antimalarial beta-carboline from the Australian marine Sponge, Ancorina sp. Tetrahedron Lett 51: 583-585.
27. Feng Y, Davis RA, Sykes ML, Avery VM, Camp D, Quinn RJ (2010) Antitrypanosomal cyclic polyketide peroxides from the Australian marine sponge Plakortis sp. J Nat Prod 73: 716-719.
28. Feng Y, Davis RA, Sykes ML, Avery VM, Carroll AR, Camp D, Quinn RJ (2010) Antitrypanosomal pyridoacridine alkaloids from the Australian ascidian, Polysyncraton echinatum. Tetrahedron Lett 51: 2477-2479.
29. Yang X, Davis RA, Buchanan MS, Duffy S, Avery VM, Camp D, Quinn RJ (2010) Antimalarial bromotyrosine derivatives from the Australian marine sponge Hyattella sp. J Nat Prod 73: 985-987.
30. Lopez M, Paul B, Hofmann A, Innocenti A, Vullo D, Supuran C, Poulsen S (2009) S-glycosyl primary sulfonamides-a new structural class for selective inhibition of cancer-associated carbonic anhydrases. J Med Chem 52: 6421-6432.
31. Besier B (2007) New anthelmintics for livestock: the time is right. Trends Parasitol 23: 21-24.
32. Kutz S, Dobson A, Hoberg E (2009) Where are the parasites? Science 326: 1187-1188.
33. Cantacessi C, Campbell BE, Visser A, Geldhof P, Nolan MJ, Nisbet AJ, Matthews JB, Loukas A, Hofmann A, Otranto D et al (2009) A portrait of the "SCP/TAPS" proteins of eukaryotes-developing a framework for fundamental research and biotechnological outcomes. Biotechnol Adv 27: 376-388.
34. Hanks SK, Quinn AM, Hunter T (1988) The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241: 42-52.
35. Barford D, Das A, Egloff M (1998) The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Annu Rev Biophys Biomol Struct 27: 133-164.
36. Hu M, Abs El-Osta YG, Campbell BE, Boag PR, Nisbet AJ, Beveridge I, Gasser RB (2007) Trichostrongylus vitrinus (Nematoda: Strongylida): molecular characterisation and transcriptional analysis of Tv-stp-1, a serine/threonine phosphatase gene. Exp Parasitol 117: 22-34.
37. Campbell B, Rabelo E, Hofmann A, Hu M, Gasser R (2010) Characterization of a Caenorhabditis elegans glc seven-like phosphatase (gsp) orthologue from Haemonchus contortus (Nematoda). Mol Cell Probes (in press).
38. Campbell BE, McCluskey A, Hofmann A, Gasser R (2010) Serine/threonine phosphatases in socioeconomically important parasitic nematodes-prospects as novel drug targets? Biotechnol Adv (in press).
39. Nolan MJ, Hofmann A, Jex AR, Gasser RB (2010) A theoretical study to establish the relationship between the three-dimensional structure of triose-phosphate isomerase of Giardia duodenalis and point mutations in the respective gene. Mol Cell Probes (in press).
40. Loukas A, Bethony J, Brooker S, Hotez P (2006) Hookworm vaccines: past, present, and future. Lancet Infect Dis 6: 733-741.
41. Muchowski PJ, Zhang L, Chang ER, Soule HR, Plow EF, Moyle M (1994) Functional interaction between the integrin antagonist neutrophil inhibitory factor and the I domain of CD11b/CD18. J Biol Chem 269: 26419-26423.
42. Asojo OA, Goud G, Dhar K, Loukas A, Zhan B, Deumic V, Liu S, Borgstahl GEO, Hotez PJ (2005) X-ray structure of Na-ASP-2, a pathogenesis-related-1 protein from the nematode parasite, Necator americanus, and a vaccine antigen for human hookworm infection. J Mol Biol 346: 801-814.
43. Henriksen A, King TP, Mirza O, Monsalve RI, Meno K, Ipsen H, Larsen JN, Gajhede M, Spangfort MD (2001) Major venom allergen of yellow jackets, Ves v 5: structural characterization of a pathogenesis-related protein superfamily. Proteins 45: 438-448.
44. Fernández C, Szyperski T, Bruyère T, Ramage P, Mösinger E, Wüthrich K (1997) NMR solution structure of the pathogenesis-related protein P14a. J Mol Biol 266: 576-593.
45. Hofmann A, Zdanov A, Genschik P, Ruvinov S, Filipowicz W, Wlodawer A (2000) Structure and mechanism of activity of the cyclic phosphodiesterase of Appr>p, a product of the tRNA splicing reaction. EMBO J 19: 6207-6217.
46. Hofmann A, Huber R (2003) Structural conservation and functional versatility: allostery as a common annexin feature. In: Bandorowicz-Pikula J (ed) Annexins: biological importance and annexin-related pathologies. Landes Bioscience, Georgetown.
47. Sopkova J, Renouard M, Lewit-Bentley A (1993) The crystal structure of a new high-calcium form of annexin V. J Mol Biol 234: 816-825.
48. Pathuri P, Nguyen ET, Svard SG, Luecke H (2007) Apo and calcium-bound crystal structures of alpha-11 giardin, an unusual annexin from Giardia lamblia. J Mol Biol 368: 493-508.
49. Pathuri P, Nguyen ET, Ozorowski G, Svärd SG, Luecke H (2009) Apo and calcium-bound crystal structures of cytoskeletal protein alpha-14 giardin (annexin E1) from the intestinal protozoan parasite Giardia lamblia. J Mol Biol 385: 1098-1112.
50. Hofmann A (2004) Annexins in the plant kingdom-perspectives and potentials. Annexins 1: 51-61.
51. Dabitz N, Hu NJ, Yusof AM, Tranter N, Winter A, Daley M, Zschörnig O, Brisson A, Hofmann A (2005) Structural determinants for plant annexin-membrane interactions. Biochemistry 44: 16292-16300.
52. Hu N, Yusof A, Winter A, Osman A, Reeve A, Hofmann A (2008) The crystal structure of calcium-bound annexin Gh1 from Gossypium hirsutum indicates different mechanisms of membrane binding in plant and animal annexins. J Biol Chem 283: 18314-18322.
53. Winter A, Yusof AM, Gao E, Yan HL, Hofmann A (2006) Biochemical characterization of annexin B1 from Cysticercus cellulosae. FEBS J 273: 3238-3247.
54. Römisch J, Heimburger N (1990) Purification and characterization of six annexins from human placenta. Biol Chem Hoppe Seyler 371: 383-388.
55. Weiland M, Palm J, Griffiths W, McCaffery J, Svärd S (2003) Characterisation of alpha-1 giardin: an immunodominant Giardia lamblia annexin with glycosaminoglycan-binding activity. Int J Parasitol 33: 1341-1351.
56. Capila I, Hernaiz M, Mo Y, Mealy T, Campos B, Dedman J, Linhardt R, Seaton B (2001) Annexin V-heparin oligosaccharide complex suggests heparan sulfate-mediated assembly on cell surface. Structure 9: 57-64.
57. Hofmann A, Osman A, Leow CY, Driguez P, Jones M (2010) Parasite annexins-new molecules with potential for drug and vaccine development. BioEssays (in press).
58. Kaneko N, Ago H, Matsuda R, Inagaki E, Miyano M (1997) Crystal structure of annexin V with its ligand K-201 as a calcium channel activity inhibitor. J Mol Biol 274: 16-20.
59. Hofmann A, Escherich A, Lewit-Bentley A, Benz J, Raguenes-Nicol C, Russo-Marie F, Gerke V, Moroder L, Huber R (1998) Interactions of benzodiazepine derivatives with annexins. J Biol Chem 273: 2885-2894.
60. Parente L, Solito E (2004) Annexin 1: more than an anti-phospholipase protein. Inflamm Res 53: 125-132.
61. Meers P, Mealy T, Pavlotsky N, Tauber AI (1992) Annexin I-mediated vesicular aggregation: mechanism and role in human neutrophils. Biochemistry 31: 6372-6382.
62. Bitto E, Li M, Tikhonov AM, Schlossman ML, Cho W (2000) Mechanism of annexin I-mediated membrane aggregation. Biochemistry 39: 13469-13477.
63. Streicher WW, Lopez MM, Makhatadze GI (2009) Annexin I and annexin II n-terminal peptides binding to s100 protein family members: specificity and thermodynamic characterization. Biochemistry 48: 2788-2798.
64. Hu N, Bradshaw J, Lauter H, Buckingham J, Solito E, Hofmann A (2008) Membrane-induced folding and structure of membrane-bound annexin A1 N-terminal peptides-implications for annexin-induced membrane aggregation. Biophys J 94: 1773-1781.
65. Burgoyne R (2007) Neuronal calcium sensor proteins: generating diversity in neuronal Ca2+ signalling. Nat Rev Neurosci 8: 182-193.
66. Genin A, Davis S, Meziane H, Doyere V, Jeromin A, Roder J, Mallet J, Laroche S (2001) Regulated expression of the neuronal calcium sensor-1 gene during long-term potentiation in the dentate gyrus in vivo. Neuroscience 106: 571-577.
67. Braunewell K, Brackmann M, Manahan-Vaughan D (2003) Group I mGlu receptors regulate the expression of the neuronal calcium sensor protein VILIP-1 in vitro and in vivo: implications for mGlu receptor-dependent hippocampal plasticity. Neuropharmacology 44: 707-715.
68. Kabbani N, Negyessy L, Lin R, Goldman-Rakic P, Levenson R (2002) Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor. J Neurosci 22: 8476-8486.
69. Bahi N, Friocourt G, Carrié A, Graham ME, Weiss JL, Chafey P, Fauchereau F, Burgoyne RD, Chelly J (2003) IL1 receptor accessory protein like, a protein involved in X-linked mental retardation, interacts with Neuronal Calcium Sensor-1 and regulates exocytosis. Hum Mol Genet 12: 1415-1425.
70. Cheng HM, Pitcher GM, Laviolette SR, Whishaw IQ, Tong KI, Kockeritz LK, Wada T, Joza NA, Crackower M, Goncalves J et al (2002) DREAM is a critical transcriptional repressor for pain modulation. Cell 108: 31-43.
71. Mahloogi H, Gonzalez-Guerrico AM, Lopez De Cicco R, Bassi DE, Goodrow T, Braunewell KH, Klein-Szanto AJ (2003) Overexpression of the calcium sensor visinin-like protein-1 leads to a cAMP-mediated decrease of in vivo and in vitro growth and invasiveness of squamous cell carcinoma cells. Cancer Res 63: 4997-5004.
72. Heo WD, Inoue T, Park WS, Kim ML, Park BO, Wandless TJ, Meyer T (2006) PI(3, 4, 5)P3 and PI(4, 5)P2 lipids target proteins with polybasic clusters to the plasma membrane. Science 314: 1458-1461.
73. Czech MP (2000) PIP2 and PIP3: complex roles at the cell surface. Cell 100: 603-606.
74. Tang K, Hofmann A, Freund C, Danker K (2009) The cytoplasmic tail of the alpha1 integrin subunit associates with phosphoinositides. Submitted.
75. O'Callaghan DW, Haynes LP, Burgoyne RD (2005) High-affinity interaction of the N-terminal myristoylation motif of the neuronal calcium sensor protein hippocalcin with phosphatidylinositol 4, 5-bisphosphate. Biochem J 391: 231-238.
76. Braunewell KH, Brackmann M, Hofmann A (2006) VILIP-1, a novel regulator of the guanylate cyclase transduction system in neurons. Calcium Bind Proteins 1: 12-15.
77. Brackmann M, Hofmann A, Braunewell KH (2006) Structure, function and expression of members of the vilip (visinin-like protein) subfamily of neuronal calcium sensor proteins. In: Philippov P, Koch K (eds) Neuronal calcium sensor proteins. Nova Science Publisher, Hauppauge.
78. Braunewell K, Paul B, Altarche-Xifro W, Noack C, Lange K, Hofmann A (2010) Interactions of Visinin-like proteins with phospho-inositides. Aust J Chem 63: 350-356.
79. Krylov D, Hurley J (2001) Identification of proximate regions in a complex of retinal guanylyl cyclase 1 and guanylyl cyclase-activating protein-1 by a novel mass spectrometry-based method. J Biol Chem 276: 30648-30654.
80. Chen K, Wang L, Chang L (2009) Regulatory elements and functional implication for the formation of dimeric visinin-like protein-1. J Pept Sci 15: 89-94.
81. McArdle B, Hofmann A (2008) Coronin structure and implications. In: Clemen C, Eichinger L, Rybakin V (eds) The coronin family of proteins. Landes Bioscience, Austin.
82. Hudson AM, Cooley L (2008) Phylogenetic, structural and functional relationships between WD- and Kelch-repeat proteins. Subcell Biochem 48: 6-19.
83. Smith TF (2008) Diversity of WD-repeat proteins. Subcell Biochem 48: 20-30.
84. Smith TF, Gaitatzes C, Saxena K, Neer EJ (1999) The WD repeat: a common architecture for diverse functions. Trends Biochem Sci 24: 181-185.
85. Li D, Roberts R (2001) WD-repeat proteins: structure characteristics, biological function, and their involvement in human diseases. Cell Mol Life Sci 58: 2085-2097.
86. Appleton B, Wu P, Wiesmann C (2006) The crystal structure of murine coronin-1: a regulator of actin cytoskeletal dynamics in lymphocytes. Structure 14: 87-96.
87. de Hostos EL (1999) The coronin family of actin-associated proteins. Trends Cell Biol 9: 345-350.
88. Rybakin V, Clemen C (2005) Coronin proteins as multifunctional regulators of the cytoskeleton and membrane trafficking. BioEssays 27: 625-632.
89. Rosentreter A, Hofmann A, Xavier CP, Stumpf M, Noegel AA, Clemen CS (2007) Coronin 3 involvement in F-actin-dependent processes at the cell cortex. Exp Cell Res 313: 878-895.
90. Gatfield J, Albrecht I, Zanolari B, Steinmetz M, Pieters J (2005) Association of the leukocyte plasma membrane with the actin cytoskeleton through coiled coil-mediated trimeric coronin 1 molecules. Mol Biol Cell 16: 2786-2798.
91. Gandhi M, Goode B (2008) Coronin: the double-edged sword of actin dynamics. In: Clemen C, Eichinger L, Rybakin V (eds) The coronin family of proteins. Landes Bioscience, Georgetown.
92. Xavier C, Rosentreter A, Reimann J, Cornfine S, Linder S, van Vliet V, Hofmann A, Morgan RO, Fernandez M, Stumpf M et al (2009) Structural and functional diversity of novel coronin-1C (CRN2) isoforms. J Mol Biol 393: 287-299.
93. Cai L, Holoweckyj N, Schaller M, Bear J (2005) Phosphorylation of coronin 1B by protein kinase C regulates interaction with Arp2/3 and cell motility. J Biol Chem 280: 31913-31923.
94. Spoerl Z, Stumpf M, Noegel AA, Hasse A (2002) Oligomerization, F-actin interaction, and membrane association of the ubiquitous mammalian coronin 3 are mediated by its carboxyl terminus. J Biol Chem 277: 48858-48867.
95. Schutt CE, Lindberg U (2000) The new architectonics: an invitation to structural biology. Anat Rec 261: 198-216.
96. DeLano W (2002) The PyMOL Molecular Graphics System. http://www. pymol. org.